Skip to search.
 STI Down 0.69%

Galena Biopharma, Inc. (GALE)

-NasdaqCM
1.50 Up 0.01(0.67%) 29 Aug 04:00 SGT
Add to Portfolio
Prev Close:1.49
Open:1.50
Bid:N/A
Ask:1.62 x 200
1y Target Est:5.10
Beta:0.440397
Earnings Date:2 Nov - 6 Nov (Est.)
Day's Range:1.45 - 1.52
52wk Range:1.10 - 2.50
Volume:1,100,497
Avg Vol (3m):2,751,600
Market Cap:242.57M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GALEUp 0.67%242.57M
CELGUp 0.81%98.06B
VSTMUp 7.14%221.38M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.33
Quarterly EPS Est (Sep-15) :-0.07
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs across cancer care. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback